Marcellin, P., Ahn, S. H., Chuang, W., Hui, A. J., Tabak, F., Mehta, R., Petersen, J., Lee, C., Ma, X., Caruntu, F. A., Tak, W. Y., Elkhashab, M., Lin, L., Wu, G., Martins, E. B., Charuworn, P., Yee, L. J., Lim, S. G., Foster, G. R., Fung, S., Morano, L., Samuel, D., Agarwal, K., Idilman, R., Strasser, S. I., Buti, M., Gaeta, G. B., Papatheodoridis, G., Flisiak, R., & Chan, H. L. Y. (2016). predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa‐2a combination therapy for chronic hepatitis B. Alimentary pharmacology & therapeutics, 44(9), 957–966. http://access.bl.uk/ark:/81055/vdc_100037125974.0x000052